Zoono Group (ZNO)
Zoono Group Ltd. is a pharmaceutical and biotechnology company, which engages in the development, manufacture, and sale of antimicrobial technology effective against all pathogens including bacteria, viruses, mould, algae, and fungi. Its products include aerosol-based sprays, surface sanitizers, treatment of acne, and mould remediation. The company was founded on November 26, 2009 and is headquartered in Sydney, Australia.
|Market Price at 22-11-2017||$0.40|
|Price to Earnings Ratio||-2.07|
|Market Capitalisation||$2.89 (million)|
|Return on Equity (ROE)||0%|